TP53I3
Basic information
Region (hg38): 2:24077433-24085861
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TP53I3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 8 | |||||
missense | 14 | 19 | ||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 1 | |||||
Total | 0 | 0 | 14 | 12 | 4 |
Variants in TP53I3
This is a list of pathogenic ClinVar variants found in the TP53I3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-24077571-A-C | TP53I3-related disorder | Likely benign (Jan 22, 2024) | ||
2-24077572-T-C | TP53I3-related disorder | Likely benign (Apr 09, 2024) | ||
2-24077628-A-G | not specified | Uncertain significance (Mar 20, 2023) | ||
2-24077647-G-C | not specified | Uncertain significance (Aug 05, 2024) | ||
2-24077655-G-A | not specified | Uncertain significance (Sep 07, 2022) | ||
2-24077693-T-C | TP53I3-related disorder | Benign (Oct 30, 2019) | ||
2-24077699-G-A | TP53I3-related disorder • not specified | Likely benign (Feb 26, 2024) | ||
2-24077769-A-G | TP53I3-related disorder | Likely benign (Sep 04, 2024) | ||
2-24079447-A-C | TP53I3-related disorder | Likely benign (Oct 26, 2022) | ||
2-24079456-A-G | TP53I3-related disorder | Likely benign (Mar 17, 2023) | ||
2-24079475-A-G | not specified | Uncertain significance (Mar 29, 2023) | ||
2-24079505-G-C | TP53I3-related disorder | Likely benign (Jul 19, 2022) | ||
2-24079506-A-G | not specified | Uncertain significance (Nov 17, 2022) | ||
2-24079514-G-T | not specified | Uncertain significance (May 07, 2024) | ||
2-24079528-A-G | TP53I3-related disorder | Likely benign (Jan 18, 2024) | ||
2-24079560-G-A | TP53I3-related disorder | Uncertain significance (Jul 18, 2024) | ||
2-24079593-C-T | TP53I3-related disorder | Likely benign (Mar 05, 2022) | ||
2-24079594-C-T | TP53I3-related disorder | Likely benign (May 30, 2024) | ||
2-24080826-G-T | not specified | Uncertain significance (Nov 12, 2024) | ||
2-24080835-C-T | TP53I3-related disorder | Benign (Dec 18, 2019) | ||
2-24080836-G-A | TP53I3-related disorder • not specified | Uncertain significance (May 24, 2023) | ||
2-24080853-C-G | TP53I3-related disorder | Likely benign (Aug 04, 2022) | ||
2-24080899-A-T | not specified | Uncertain significance (Mar 18, 2024) | ||
2-24080921-C-T | not specified | Uncertain significance (May 02, 2024) | ||
2-24080953-C-A | not specified | Uncertain significance (Feb 21, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TP53I3 | protein_coding | protein_coding | ENST00000238721 | 5 | 8429 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.95e-11 | 0.0343 | 125185 | 0 | 562 | 125747 | 0.00224 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.512 | 166 | 186 | 0.894 | 0.00000945 | 2126 |
Missense in Polyphen | 47 | 56.436 | 0.8328 | 677 | ||
Synonymous | 0.394 | 74 | 78.4 | 0.943 | 0.00000428 | 711 |
Loss of Function | -0.310 | 15 | 13.8 | 1.09 | 7.35e-7 | 151 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00775 | 0.00777 |
Ashkenazi Jewish | 0.000992 | 0.000993 |
East Asian | 0.000327 | 0.000326 |
Finnish | 0.00106 | 0.00106 |
European (Non-Finnish) | 0.00300 | 0.00298 |
Middle Eastern | 0.000327 | 0.000326 |
South Asian | 0.00102 | 0.00101 |
Other | 0.00164 | 0.00147 |
dbNSFP
Source:
- Function
- FUNCTION: May be involved in the generation of reactive oxygen species (ROS). Has low NADPH-dependent beta-naphthoquinone reductase activity, with a preference for 1,2-beta-naphthoquinone over 1,4-beta-naphthoquinone. Has low NADPH-dependent diamine reductase activity (in vitro). {ECO:0000269|PubMed:19349281}.;
- Pathway
- p53 signaling pathway - Homo sapiens (human);TP53 Regulates Transcription of Cell Death Genes;Gene expression (Transcription);Generic Transcription Pathway;TP53 Regulates Transcription of Cell Death Genes;RNA Polymerase II Transcription;p73 transcription factor network;TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain;Validated transcriptional targets of TAp63 isoforms;Transcriptional Regulation by TP53;Direct p53 effectors
(Consensus)
Recessive Scores
- pRec
- 0.139
Intolerance Scores
- loftool
- 0.879
- rvis_EVS
- 0.55
- rvis_percentile_EVS
- 81.48
Haploinsufficiency Scores
- pHI
- 0.218
- hipred
- N
- hipred_score
- 0.453
- ghis
- 0.404
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.925
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- NADP metabolic process;regulation of apoptotic process;oxidation-reduction process
- Cellular component
- cytosol
- Molecular function
- NADPH:quinone reductase activity;protein homodimerization activity;quinone binding;NADPH binding